TOOKAD® Soluble

DRUG2 trials

Sponsors

Steba Biotech S.A.

Conditions

Prostate Cancer

Phase 3

Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.

CompletedNCT01310894

Steba Biotech S.A.Prostate Cancer

Start: 2011-02-28End: 2015-08-31Updated: 2019-07-11

Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer

CompletedNCT01875393

Steba Biotech S.A.Prostate Cancer

Start: 2013-05-31End: 2015-03-31Updated: 2016-04-19

Related Papers

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.

2016-12-20225 citations